Home LiteratureArticle Details
PMID: 11438682 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't

The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia.

Fuchs U, Rehkamp G, Haas OA, Slany R, Kōnig M, Bojesen S, Bohle RM, Damm-Welk C, Ludwig WD, Harbott J, Borkhardt A

Abstract

We have cloned a fusion partner of the MLL gene at 11q23 and identified it as the gene encoding the human formin-binding protein 17, FBP17. It maps to chromosome 9q34 centromeric to ABL. The gene fusion results from a complex chromosome rearrangement that was resolved by fluorescence in situ hybridization with various probes on chromosomes 9 and 11 as an ins(11;9)(q23;q34)inv(11)(q13q23). The rearrangement resulted in a 5'-MLL/FBP17-3' fusion mRNA. We retrovirally transduced murine-myeloid progenitor cells with MLL/FBP17 to test its transforming ability. In contrast to MLL/ENL, MLL/ELL and other MLL-fusion genes, MLL/FBP17 did not give a positive readout in a serial replating assay. Therefore, we assume that additional cooperating genetic abnormalities might be needed to establish a full malignant phenotype. FBP17 consists of a C-terminal Src homology 3 domain and an N-terminal region that is homologous to the cell division cycle protein, cdc15, a regulator of the actin cytoskeleton in Schizosaccharomyces pombe. Both domains are separated by a consensus Rho-binding motif that has been identified in different Rho-interaction partners such as Rhotekin and Rhophilin. We evaluated whether FBP17 and members of the Rho family interact in vivo with a yeast two-hybrid assay. None of the various Rho proteins tested, however, interacted with FBP17. We screened a human kidney library and identified a sorting nexin, SNX2, as a protein interaction partner of FBP17. These data provide a link between the epidermal growth factor receptor pathway and an MLL fusion protein.

MeSH Terms
Artificial Gene Fusion Base Sequence Carrier Proteins/genetics,metabolism Cell Nucleus/metabolism Cell Transformation, Neoplastic Chromosome Mapping Chromosomes, Human, Pair 9 DNA, Complementary DNA-Binding Proteins/genetics,metabolism Fatty Acid-Binding Proteins Histone-Lysine N-Methyltransferase Humans In Situ Hybridization, Fluorescence/methods Infant Leukemia, Myelomonocytic, Acute/genetics,metabolism,pathology Male Molecular Sequence Data Myeloid-Lymphoid Leukemia Protein Proto-Oncogenes Tissue Distribution Transcription Factors Vesicular Transport Proteins
Chemicals
Carrier Proteins DNA, Complementary DNA-Binding Proteins FNBP1 protein, human Fatty Acid-Binding Proteins KMT2A protein, human Transcription Factors Vesicular Transport Proteins Myeloid-Lymphoid Leukemia Protein Histone-Lysine N-Methyltransferase
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Fuchs U
Department of Pediatric Hematology and Oncology, University of Giessen, 35392 Giessen, Germany.
Rehkamp G
Haas O A
Slany R
Kōnig M
Bojesen S
Bohle R M
Damm-Welk C
Ludwig W D
Harbott J
Borkhardt A
References (36)
36 references, click to expand
  1. Versatile retroviral vectors for potential use in gene therapy.
    Gene Ther. 1994 Mar;1(2):136-8 PMID: 7584069
  2. Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus.
    Oncogene. 1997 Oct 2;15(14):1681-7 PMID: 9349501
  3. Enhanced degradation of EGF receptors by a sorting nexin, SNX1.
    Science. 1996 May 17;272(5264):1008-10 PMID: 8638121
  4. The role of chromosome translocations in leukemogenesis.
    Semin Hematol. 1999 Oct;36(4 Suppl 7):59-72 PMID: 10595755
  5. The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.
    Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9168-73 PMID: 10908648
  6. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia.
    EMBO J. 2000 Sep 1;19(17):4655-64 PMID: 10970858
  7. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
    Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10984-9 PMID: 10995463
  8. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.
    Blood. 2000 Dec 1;96(12):3887-93 PMID: 11090074
  9. Human orthologs of yeast vacuolar protein sorting proteins Vps26, 29, and 35: assembly into multimeric complexes.
    Mol Biol Cell. 2000 Dec;11(12):4105-16 PMID: 11102511
  10. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.
    Nature. 1982 Dec 23;300(5894):765-7 PMID: 6960256
  11. 'Formins': proteins deduced from the alternative transcripts of the limb deformity gene.
    Nature. 1990 Aug 30;346(6287):850-3 PMID: 2392150
  12. Disruption of formin-encoding transcripts in two mutant limb deformity alleles.
    Nature. 1990 Aug 30;346(6287):853-5 PMID: 2392151
  13. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.
    Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10735-9 PMID: 1720549
  14. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.
    Mol Cell Biol. 1992 Apr;12(4):1687-97 PMID: 1549122
  15. Formins: phosphoprotein isoforms encoded by the mouse limb deformity locus.
    Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5554-8 PMID: 8516300
  16. eps15, a novel tyrosine kinase substrate, exhibits transforming activity.
    Mol Cell Biol. 1993 Sep;13(9):5814-28 PMID: 7689153
  17. Involvement of the MLL/ALL-1 gene associated with multiple point mutations of the N-ras gene in acute myeloid leukemia with t(11;17)(q23;q25)
    Blood. 1993 Oct 1;82(7):2260-1 PMID: 8400276
  18. A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL.
    Oncogene. 1994 Apr;9(4):1039-45 PMID: 8134107
  19. Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia.
    Cancer Res. 1994 May 1;54(9):2327-30 PMID: 8162575
  20. Chromosomal translocations in human cancer.
    Nature. 1994 Nov 10;372(6502):143-9 PMID: 7969446
  21. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.
    Mol Cell Biol. 1998 Jan;18(1):122-9 PMID: 9418860
  22. RAS mutations in pediatric leukemias with MLL gene rearrangements.
    Genes Chromosomes Cancer. 1998 Mar;21(3):270-5 PMID: 9523205
  23. Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants.
    Leukemia. 1998 May;12(5):811-22 PMID: 9593286
  24. t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes.
    Proc Natl Acad Sci U S A. 1998 May 26;95(11):6413-8 PMID: 9600980
  25. Identification of a family of sorting nexin molecules and characterization of their association with receptors.
    Mol Cell Biol. 1998 Dec;18(12):7278-87 PMID: 9819414
  26. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
    Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):680-5 PMID: 9892693
  27. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).
    Proc Natl Acad Sci U S A. 1999 May 25;96(11):6428-33 PMID: 10339604
  28. Mll rearrangements in haematological malignancies: lessons from clinical and biological studies.
    Br J Haematol. 1999 Sep;106(3):614-26 PMID: 10468849
  29. Correlation of two-hybrid affinity data with in vitro measurements.
    Mol Cell Biol. 1995 Oct;15(10):5820-9 PMID: 7565735
  30. Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain.
    J Biol Chem. 1996 Jun 7;271(23):13556-60 PMID: 8662891
  31. Distribution of TP53 mutations among acute leukemias with MLL rearrangements.
    Genes Chromosomes Cancer. 1996 Jan;15(1):48-53 PMID: 8824725
  32. Aetiology of acute leukaemia.
    Lancet. 1997 Feb 1;349(9048):344-9 PMID: 9024390
  33. FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands.
    EMBO J. 1997 May 1;16(9):2376-83 PMID: 9171351
  34. A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton.
    Curr Biol. 1997 Jul 1;7(7):479-87 PMID: 9210375
  35. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.
    EMBO J. 1997 Jul 16;16(14):4226-37 PMID: 9250666
  36. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.
    EMBO J. 1996 Mar 1;15(5):1045-54 PMID: 8605874
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2001-07-17
Epub
2001-00-03
Pages
8756-61
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC37508
Subset
IM
Databases
GENBANK
AF265550
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com